Skip to main content

Advertisement

Table 1 Clinical and biochemical characteristics of the 961 participants

From: Impact of chronic diuretic treatment on glucose homeostasis

  Mean ± SD Median (Q1-Q3)
Age (y) 49 ± 14 50 (38–60)
Body weight (kg) 73.6 ± 15.9 72.0 (61.6 - 83.5
BMI (kg/m2) 27.9 ± 5.4 27.2 (24.1-31.0)
Circumferences   
   Waist (cm) 94.3 ± 14.5 94.0 (85.0 - 103.0)
   Hip (cm) 104.6 ± 12.3 104.0 (98.0 - 110.0)
Systolic BP (mmHg) 129 ± 16 128 (118–139)
Diastolic BP (mmHg) 79 ± 10 78 (72–85)
Heart rate (beats/min) 74 ± 11 73 (66–81)
Random capillary blood glucose (mg/dl) 91 ± 12 90 (82–97)
Blood concentration of n = 507  
   glycated hemoglobin% 5.6 ± 0.4 5.5 (5.3 - 5.8)
mmol/mol 37.4 ± 4.8 36.6 (34.4 - 39.9)
   glucose (mg/dl) 88 ± 21 85 (75–97)
   total cholesterol (mg/dl) 213 ± 39 212 (185–240)
   hdl cholesterol (mg/dl) 59 ± 15 58 (49–67)
   triglycerides (mg/dl) 101 ± 49 90 (68–121)
   ldl cholesterol (mg/dl) 133 ± 36 131 (108–161)
   uric acid (mg/dl) 5.0 ± 1.4 4.7 (3.9 - 5.9)
   insulin (μu/ml) 9.6 ± 5.8 8.2 (5.6 - 11.8)
HOMA-IR 2.2 ± 1.5 1.8 (1.2 - 2.7)
HOMA-β 141.8 ± 104.5 117.9 (80.0 - 171.4)
   Creatinine (mg/dL) 0.83 ± 0.21 0.79 (0.69 - 0.94)
   eGFR-MDRD (mL/min/1.73 m2) 91.8 ± 20.3 90.3 (76.5 – 94.4)
  1. BMI: body mass index; BP: blood pressure; eGFR: estimated glomerular filtration rate; HDL: high-density lipoproteins; HOMA-IR: homeostasis model assessment of insulin resistance; HOMA-β: homeostasis model assessment of β-cell function; LDL: low-density lipoproteins; MDRD: modification of diet in renal disease study.